We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$124B
AUM Growth
-$818M
(-0.66%)
Cap. Flow
-$3.27B
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
4,253
New
85
Increased
832
Reduced
2,978
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$588M |
| 2 |
CRH
CRH
|
+$47.1M |
| 3 |
Carvana
CVNA
|
+$34.4M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$33.9M |
| 5 |
Pinterest
PINS
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$326M |
| 2 |
Apple
AAPL
|
+$286M |
| 3 |
Microsoft
MSFT
|
+$251M |
| 4 |
MRSH
Marsh
MRSH
|
+$174M |
| 5 |
Amazon
AMZN
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Financials | 13.22% |
| 3 | Consumer Discretionary | 10.75% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Adaptive Biotechnologies
ADPT
$3.95B
| $3M | ﹤0.01% |
184,636
-19,307
| -9% | -$315K |
|
1652
Loar Holdings
LOAR
$7.24B
| $2.99M | ﹤0.01% |
43,961
-1,619
| -4% | -$118K |
|
1653
Magnite
MGNI
$3.52B
| $2.99M | ﹤0.01% |
183,945
-33,362
| -15% | -$554K |
|
1654
Vital Farms
VITL
$474M
| $2.98M | ﹤0.01% |
93,398
+43,480
| +87% | +$1.53M |
|
|
AAT
1655
American Assets Trust
AAT
$1.4B
| $2.97M | ﹤0.01% |
156,691
-4,221
| -3% | -$81.5K |
|
1656
Cogent Communications
CCOI
$556M
| $2.96M | ﹤0.01% |
137,461
+196
| +0.1% | +$5.79K |
|
1657
AdaptHealth
AHCO
$778M
| $2.96M | ﹤0.01% |
297,359
-12,877
| -4% | -$123K |
|
|
APLS
1658
DELISTED
Apellis Pharmaceuticals
APLS
| $2.94M | ﹤0.01% |
116,917
-512
| -0.4% | -$12K |
|
1659
iShares MSCI China A ETF
CNYA
$206M
| $2.94M | ﹤0.01% |
84,920
+350
| +0.4% | +$11.9K |
|
1660
Genius Sports
GENI
$2.3B
| $2.93M | ﹤0.01% |
266,091
-40,015
| -13% | -$436K |
|
1661
CG Oncology
CGON
$6.64B
| $2.93M | ﹤0.01% |
70,601
-10,157
| -13% | -$420K |
|
1662
Ocular Therapeutix
OCUL
$2.17B
| $2.93M | ﹤0.01% |
241,321
+21,313
| +10% | +$259K |
|
1663
Remitly
RELY
$5.49B
| $2.93M | ﹤0.01% |
212,208
-31,842
| -13% | -$463K |
|
1664
Newell Brands
NWL
$2.6B
| $2.93M | ﹤0.01% |
786,490
-1,186
| -0.2% | -$4.79K |
|
|
CWEN.A
1665
DELISTED
Clearway Energy Class A
CWEN.A
| $2.92M | ﹤0.01% |
93,089
+5,521
| +6% | +$173K |
|
|
ACLX
1666
DELISTED
Arcellx
ACLX
| $2.89M | ﹤0.01% |
44,352
-8,076
| -15% | -$644K |
|
1667
Twist Bioscience
TWST
$7.56B
| $2.89M | ﹤0.01% |
91,122
-4,085
| -4% | -$127K |
|
|
PMT
1668
PennyMac Mortgage Investment
PMT
$830M
| $2.89M | ﹤0.01% |
230,185
-29,070
| -11% | -$362K |
|
1669
United Parks & Resorts
PRKS
$2.05B
| $2.89M | ﹤0.01% |
79,490
-2,709
| -3% | -$113K |
|
1670
First Busey Corp
BUSE
$2.58B
| $2.88M | ﹤0.01% |
121,147
-9,534
| -7% | -$224K |
|
1671
Employers Holdings
EIG
$873M
| $2.87M | ﹤0.01% |
66,382
-3,947
| -6% | -$161K |
|
|
NVO
1672
Novo Nordisk
NVO
$202B
| $2.85M | ﹤0.01% |
56,080
-1,302
| -2% | -$66.6K |
|
1673
Bristow Group
VTOL
$1.38B
| $2.85M | ﹤0.01% |
77,701
-4,877
| -6% | -$184K |
|
1674
Deluxe
DLX
$1.1B
| $2.84M | ﹤0.01% |
127,282
-6,973
| -5% | -$140K |
|
1675
Madison Square Garden
MSGE
$4.09B
| $2.84M | ﹤0.01% |
52,714
-8,398
| -14% | -$404K |
|
Similar funds
RhumbLine Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, RhumbLine Advisers held 4,253 positions worth $124B, down 0.66% from $125B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.6%. RhumbLine Advisers opened 85 new positions and exited 67, leaving the 4,253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q4 2025 buy was Qnity Electronics Inc: 399,119 shares worth $32.6M.
- RhumbLine Advisers added most to iShares Russell 3000 ETF in Q4 2025, an estimated $588M increase.
- RhumbLine Advisers's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $326M.
- RhumbLine Advisers fully exited Kellanova in Q4 2025, selling an estimated $52.6M.
- RhumbLine Advisers's ten largest holdings make up 33% of its $124B portfolio in Q4 2025.
- RhumbLine Advisers opened 85 new positions and closed 67 in Q4 2025.
- RhumbLine Advisers's portfolio value fell 0.66% quarter-over-quarter to $124B.
Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.